John A Dodson
Biographic Data
| ID | 5540635 |
|---|---|
| NAME | John A Dodson |
| GIVEN NAMES | John A |
| FAMILY NAME | Dodson |
| SIGNATURE | DODSON J A |
| AFFILIATIONS | Yale University |
| ORCID | 0000-0003-0163-3013 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
Virtual Primary Care—Is Its Expansion Due to Covid-19 All Upside
Virtual primary care has long been promoted as the future of health care in the US. Despite this promise, progress until recently had been slow, in part because of limited reimbursement, restrictions on where telehealth could be delivered, interstate care prohibitions, discomfort with technology, privacy concerns, and limited public enthusiasm
Risk Stratification in Older Patients With Acute Myocardial Infarction
Physicians reported limitations of available risk models when applied to older adults with AMI. New models are needed to guide AMI treatment in this population
Effect of β-Blockers on Cardiac and Pulmonary Events and Death in Older Adults With Cardiovascular Disease and Chronic Obstructive Pulmonary Disease
CONTEXT: In older adults with multiple conditions, medications may not impart the same benefits seen in patients who are younger or without multimorbidity. Furthermore, medications given for one condition may adversely affect other outcomes. β-Blocker use with coexisting cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD) is such a situation. OBJECTIVE: To determine the effect of β-blocker use on cardiac and pulmonary ou…
No prominent works on this page.
Effect of β-Blockers on Cardiac and Pulmonary Events and Death in Older Adults With Cardiovascular Disease and Chronic Obstructive Pulmonary Disease
CONTEXT: In older adults with multiple conditions, medications may not impart the same benefits seen in patients who are younger or without multimorbidity. Furthermore, medications given for one condition may adversely affect other outcomes. β-Blocker use with coexisting cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD) is such a situation. OBJECTIVE: To determine the effect of β-blocker use on cardiac and pulmonary ou…
Risk Stratification in Older Patients With Acute Myocardial Infarction
Physicians reported limitations of available risk models when applied to older adults with AMI. New models are needed to guide AMI treatment in this population
Virtual Primary Care—Is Its Expansion Due to Covid-19 All Upside
Virtual primary care has long been promoted as the future of health care in the US. Despite this promise, progress until recently had been slow, in part because of limited reimbursement, restrictions on where telehealth could be delivered, interstate care prohibitions, discomfort with technology, privacy concerns, and limited public enthusiasm
Internal Medicine (3 works) · Medicine (3 works) · Heart Failure Treatment and Management (2 works) · Population (2 works) · 2019-20 coronavirus outbreak (1 work) · Acute Myocardial Infarction Research (1 work) · Asthma (1 work) · Cardiac, Anesthesia and Surgical Outcomes (1 work) · Cardiology (1 work) · Chronic Disease Management Strategies (1 work)